TREATMENT OF INCLUSION-BODY MYOSITIS WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN

被引：114

作者：

SOUEIDAN, SA ^{[1
]}

DALAKAS, MC ^{[1
]}

机构：

[1] NINCDS,NEUROMUSCULAR DIS SECT,BLDG 10,ROOM 4N248,BETHESDA,MD 20892

来源：

NEUROLOGY | 1993年 / 43卷 / 05期

关键词：

D O I：

10.1212/WNL.43.5.876

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We report the treatment of four patients with inclusion-body myositis (IBM) and severe slowly progressive weakness using high-dose intravenous immunoglobulin (IVIg). After two monthly infusions, the strength of the proximal and less atrophic muscle groups improved or normalized in three of the four patients. The improvement lasted from 2 to 4 months. Intravenous immunoglobulin is the first treatment modality to improve the strength of some muscles in patients with this disabling inflammatory myopathy. In view of the high cost of IVIg, the unexpected but encouraging results from this pilot study warrant a controlled trial.

引用

页码：876 / 879

页数：4

共 15 条

[1] MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .5. IDENTIFICATION AND QUANTITATION OF T8+ CYTO-TOXIC AND T8+ SUPPRESSOR CELLS [J].

ARAHATA, K ;

ENGEL, AG .

ANNALS OF NEUROLOGY, 1988, 23 (05) :493-499

[2] INCLUSION BODY MYOSITIS - DISTINCT VARIETY OF IDIOPATHIC INFLAMMATORY MYOPATHY [J].

CARPENTER, S ;

KARPATI, G ;

HELLER, I ;

EISEN, A .

NEUROLOGY, 1978, 28 (01) :8-17

[3] EFFICACY OF INTRAVENOUS GAMMA-GLOBULIN THERAPY IN CHRONIC REFRACTORY POLYMYOSITIS AND DERMATOMYOSITIS - AN OPEN STUDY WITH 20 ADULT PATIENTS [J].

CHERIN, P ;

HERSON, S ;

WECHSLER, B ;

PIETTE, JC ;

BLETRY, O ;

COUTELLIER, A ;

ZIZA, JM ;

GODEAU, P .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) :162-168

[4] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF DEMYELINATING NEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY [J].

COOK, D ;

DALAKAS, M ;

GALDI, A ;

BIONDI, D ;

PORTER, H .

NEUROLOGY, 1990, 40 (02) :212-214

[5] POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].

DALAKAS, MC .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498

[6]

DALAKAS MC, 1992, NEUROPHARMACOLOGY, V5, P327

[7]

DWYER JM, 1992, NEW ENGL J MED, V326, P107

[8]

ENGLEHARD D, 1986, J PEDIATR, V108, P77

[9] HIGH-DOSE INTRAVENOUS HUMAN-IMMUNOGLOBULIN IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY [J].

FAED, JM ;

DAY, B ;

POLLOCK, M ;

TAYLOR, PK ;

NUKADA, H ;

HAMMONDTOOKE, GD .

NEUROLOGY, 1989, 39 (03) :422-425

[10]

FURUSHO K, 1984, LANCET, V2, P1055

← 1 2 →